Does glucagon-like peptide-1 (GLP-1) receptor agonist stimulation reduce alcohol intake in patients with alcohol dependence: study protocol of a randomised, double-blinded, placebo-controlled clinical trial
about
Does glucagon-like peptide-1 (GLP-1) receptor agonist stimulation reduce alcohol intake in patients with alcohol dependence: study protocol of a randomised, double-blinded, placebo-controlled clinical trial
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 2018
@uk
name
Does glucagon-like peptide-1 ( ...... cebo-controlled clinical trial
@en
Does glucagon-like peptide-1 ( ...... cebo-controlled clinical trial
@nl
type
label
Does glucagon-like peptide-1 ( ...... cebo-controlled clinical trial
@en
Does glucagon-like peptide-1 ( ...... cebo-controlled clinical trial
@nl
prefLabel
Does glucagon-like peptide-1 ( ...... cebo-controlled clinical trial
@en
Does glucagon-like peptide-1 ( ...... cebo-controlled clinical trial
@nl
P2093
P2860
P50
P1433
P1476
Does glucagon-like peptide-1 ( ...... cebo-controlled clinical trial
@en
P2093
Amanda S Brunchmann
Claus Ekstrøm
Gerda K Thomsen
Helene Benveniste
Henrik Rindom
Kerstin K Antonsen
Mathias E Jensen
Mette K Klausen
Nina le Dous
Nora D Volkow
P2860
P304
P356
10.1136/BMJOPEN-2017-019562
P407
P50
P577
2018-07-16T00:00:00Z